Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belimumab for Desensitization in Kidney Transplant Candidates
NCT01025193Phase 2Terminated
- Sponsor
- University of Pennsylvania
- Start
- Feb 2010
- Primary completion
- Oct 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of belimumab in sensitization in kidney transplantation (PRA), sponsored by University of Pennsylvania. Started Feb 2010; status: terminated.
02
Drugs
belimumab
03
Conditions
sensitization in kidney transplantation (PRA)
Beyond the preview
Go deeper on NCT01025193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01025193.